Waugh Jacob

Chief Scientific Officer at Revance Therapeutics, Inc.

Sold, on record
$2.6M
Dollars the filings state
Form 4 sales
2
Latest Sep 17, 2014
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Unusual
    Aug 18 2014

    Sold 25,000 shares at $24.47 ($612k)

    Waugh Jacob, Chief Scientific Officer

    Sold 31.9% of holdings ($1.9M position)53,333 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Revance Therapeutics, Inc.Unusual
    Sep 17 +30 days

    Sold 97,713 shares at $20.73 ($2M)

    Waugh Jacob, Chief Scientific Officer

    Sold 79.6% of holdings ($2.5M position)25,000 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Waugh Jacob
Source
Sep 17, 2014Revance Therapeutics, Inc.Chief Scientific OfficerForm 4 sale97,713$2M79.6%UnusualSEC
Aug 18, 2014Revance Therapeutics, Inc.Chief Scientific OfficerForm 4 sale25,000$612k31.9%UnusualSEC